Loading...
Targeted Therapy in Melanoma and Mechanisms of Resistance
The common mutation BRAFV600 in primary melanomas activates the mitogen-activated protein kinase/extracellular-signal-regulated kinase (MAPK/ERK) pathway and the introduction of proto-oncogene B-Raf (BRAF) and mitogen-activated protein kinase kinase (MEK) inhibitors (BRAFi and MEKi) was a breakthrou...
Na minha lista:
| Udgivet i: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7369697/ https://ncbi.nlm.nih.gov/pubmed/32605090 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21134576 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|